labfolder GmbH

Activities: Research & Development Digital

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Hi Tech Manufacturing

labfolder and NEC announce smart and scalable data storage solution for research organisations

As scientists increasingly generate more data, large research institutions start facing a pressing need to manage research data efficiently
Research & Development

The Laboratory of the Future in Dubai

European LabTech visionaries presented the Laboratory of the Future at the Merck X-Innovation Summit 23 November, 2017, in Dubai, United Arab Emirates (UAE)
Hi Tech Manufacturing

labfolder selected for the Merck Accelerator

The Berlin start-up company labfolder, which is developing an electronic lab notebook, was selected out of 475 applicants worldwide to participate in the Accelerator programme of the science and technology company Merck in Darmstadt for 3 months
Subscribe now